Genomics of therapy-related myeloid neoplasms
Haematologica
.
2020 Mar;105(3):e98-e101.
doi: 10.3324/haematol.2019.219352.
Epub 2019 Aug 14.
Authors
Teodora Kuzmanovic
1
,
Bhumika J Patel
1
,
Srinivasa R Sanikommu
1
,
Yasunobu Nagata
1
,
Hassan Awada
1
,
Cassandra M Kerr
1
,
Bartlomiej P Przychodzen
1
,
Babal K Jha
1
,
Devendra Hiwase
2
,
Deepak Singhal
2
,
Anjali S Advani
3
,
Aziz Nazha
3
,
Aaron T Gerds
3
,
Hetty E Carraway
3
,
Mikkael A Sekeres
3
,
Sudipto Mukherjee
3
,
Jaroslaw P Maciejewski
4
3
,
Tomas Radivoyevitch
1
5
Affiliations
1
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
2
Department of Haematology, Royal Adelaide Hospital, Port Road, Adelaide, Australia.
3
Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
4
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA maciejj@ccf.org.
5
Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
PMID:
31413096
PMCID:
PMC7049337
DOI:
10.3324/haematol.2019.219352
No abstract available
Publication types
Letter
MeSH terms
Genomics
Humans
Leukemia, Myeloid, Acute* / drug therapy
Leukemia, Myeloid, Acute* / genetics
Neoplasms*
Neoplasms, Second Primary*
Grants and funding
K12 CA076917/CA/NCI NIH HHS/United States
R01 HL132071/HL/NHLBI NIH HHS/United States
R35 HL135795/HL/NHLBI NIH HHS/United States